PCSA - Processa Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart

Processa Pharmaceuticals's activity chart (see below) currently has 24 price targets and 22 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 47.78% of the time, taking 153.4 days on average.

Most recent stock forecast was given by from HC WAINWRIGHT on 02-Sep-2025. First documented stock forecast 07-Dec-2020.

Best performing analysts who are covering PCSA - Processa Pharmaceuticals:

Aydin Huseynov Raghuram Selvaraju Francois Brisebois Naz Rahman

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 13-May-2024

$1

$2

1 years 2 months 19 days ago
(02-Sep-2025)

8/9 (88.89%)

$-3.7 (-78.72%)

235

Buy Since 19-Apr-2022

$1000

3 years 4 days ago
(16-Nov-2023)

0/2 (0%)

$670 (203.03%)

Buy Since 07-Dec-2020

$80

$300

3 years 7 months 17 days ago
(04-Apr-2023)

2/3 (66.67%)

$-165 (-67.35%)

297

Buy Since 02-Aug-2021

$4000

3 years 7 months 18 days ago
(03-Apr-2023)

0/4 (0%)

$2700 (207.69%)

Show more analysts

Please expand the browser size to see the chart

What is PCSA (Processa Pharmaceuticals) average time for price targets to be met?

On average it took 153 days for the stock forecasts to be reached, with an average price target met ratio of 47.78%.

Which analyst most recently updated their price target on PCSA (Processa Pharmaceuticals)?

Which analyst has the lowest performance score on PCSA (Processa Pharmaceuticals) with a proven track record?

NAZ RAHMAN

Which analyst has the most public recommendations on PCSA (Processa Pharmaceuticals)?

has 0 price targets and 0 ratings on PCSA

Which analyst is the currently most bullish on PCSA (Processa Pharmaceuticals)?

Aydin Huseynov with the highest potential upside of $78.44

Which analyst is the currently most reserved on PCSA (Processa Pharmaceuticals)?

Raghuram Selvaraju with the lowest potential downside of -$0.86
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?